- Stemline Therapeutics (NASDAQ:STML) -22% on preliminary Q4 revenue.
- More news on: Stemline Therapeutics, Inc., Avinger, Inc., DURECT Corporation, Stocks on the move, Read more ...
Market Wire News is a media platform, the information on this page was provided by SeekingAlpha via Quote Media. Read our full disclaimer.
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
News, Short Squeeze, Breakout and More Instantly...
Cannabis Industry Merger And Acquisitions In 2021 Many cannabis stocks have over the last several months been hit with a loss in trading momentum. This has led to many of the top cannabis stocks trading at lower prices. Yet so far in May pot stocks have been performing a bit more vo...